JP2015524450A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015524450A5 JP2015524450A5 JP2015525763A JP2015525763A JP2015524450A5 JP 2015524450 A5 JP2015524450 A5 JP 2015524450A5 JP 2015525763 A JP2015525763 A JP 2015525763A JP 2015525763 A JP2015525763 A JP 2015525763A JP 2015524450 A5 JP2015524450 A5 JP 2015524450A5
- Authority
- JP
- Japan
- Prior art keywords
- atoms
- compound
- het
- pharmaceutically acceptable
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 tetrahydroimidazolyl Chemical group 0.000 claims 22
- 239000000203 mixture Substances 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 9
- 125000004432 carbon atom Chemical group C* 0.000 claims 8
- 239000012453 solvate Substances 0.000 claims 8
- 229910052801 chlorine Inorganic materials 0.000 claims 5
- 229910052731 fluorine Inorganic materials 0.000 claims 5
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 125000002393 azetidinyl group Chemical group 0.000 claims 3
- 125000002757 morpholinyl group Chemical group 0.000 claims 3
- 125000003566 oxetanyl group Chemical group 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000004193 piperazinyl group Chemical group 0.000 claims 3
- 125000003386 piperidinyl group Chemical group 0.000 claims 3
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 3
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 3
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 3
- 125000005871 1,3-benzodioxolyl group Chemical group 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 2
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 2
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000004185 ester group Chemical group 0.000 claims 2
- 125000002541 furyl group Chemical group 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 125000002883 imidazolyl group Chemical group 0.000 claims 2
- 125000005945 imidazopyridyl group Chemical group 0.000 claims 2
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 2
- 125000001041 indolyl group Chemical group 0.000 claims 2
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 claims 2
- 125000000842 isoxazolyl group Chemical group 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 2
- 125000002971 oxazolyl group Chemical group 0.000 claims 2
- 210000003800 pharynx Anatomy 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 125000002098 pyridazinyl group Chemical group 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- 125000005493 quinolyl group Chemical group 0.000 claims 2
- 125000003831 tetrazolyl group Chemical group 0.000 claims 2
- 125000000335 thiazolyl group Chemical group 0.000 claims 2
- 125000001425 triazolyl group Chemical group 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000001738 Nervous System Trauma Diseases 0.000 claims 1
- 238000006069 Suzuki reaction reaction Methods 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 210000000481 breast Anatomy 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 210000000621 bronchi Anatomy 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 201000007455 central nervous system cancer Diseases 0.000 claims 1
- 210000003679 cervix uteri Anatomy 0.000 claims 1
- 210000000038 chest Anatomy 0.000 claims 1
- 210000001072 colon Anatomy 0.000 claims 1
- 125000005052 dihydropyrazolyl group Chemical group N1(NCC=C1)* 0.000 claims 1
- 125000004925 dihydropyridyl group Chemical group N1(CC=CC=C1)* 0.000 claims 1
- 125000005054 dihydropyrrolyl group Chemical group [H]C1=C([H])C([H])([H])C([H])([H])N1* 0.000 claims 1
- 125000005879 dioxolanyl group Chemical group 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 210000003238 esophagus Anatomy 0.000 claims 1
- 210000001508 eye Anatomy 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 210000003128 head Anatomy 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 210000000867 larynx Anatomy 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 210000001165 lymph node Anatomy 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 210000000214 mouth Anatomy 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 210000003739 neck Anatomy 0.000 claims 1
- 208000028412 nervous system injury Diseases 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 210000001672 ovary Anatomy 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 210000000496 pancreas Anatomy 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 210000000664 rectum Anatomy 0.000 claims 1
- 230000001850 reproductive effect Effects 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 210000001550 testis Anatomy 0.000 claims 1
- 125000005942 tetrahydropyridyl group Chemical group 0.000 claims 1
- 210000001685 thyroid gland Anatomy 0.000 claims 1
- 210000003932 urinary bladder Anatomy 0.000 claims 1
- 210000004291 uterus Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12005752.6 | 2012-08-08 | ||
| EP12005752 | 2012-08-08 | ||
| PCT/EP2013/002085 WO2014023390A2 (en) | 2012-08-08 | 2013-07-12 | (aza-)isoquinolinone derivatives |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017142160A Division JP6333450B2 (ja) | 2012-08-08 | 2017-07-21 | （アザ−）イソキノリノン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015524450A JP2015524450A (ja) | 2015-08-24 |
| JP2015524450A5 true JP2015524450A5 (enExample) | 2016-09-01 |
| JP6247294B2 JP6247294B2 (ja) | 2017-12-13 |
Family
ID=48793165
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015525763A Expired - Fee Related JP6247294B2 (ja) | 2012-08-08 | 2013-07-12 | （アザ−）イソキノリノン誘導体 |
| JP2017142160A Expired - Fee Related JP6333450B2 (ja) | 2012-08-08 | 2017-07-21 | （アザ−）イソキノリノン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017142160A Expired - Fee Related JP6333450B2 (ja) | 2012-08-08 | 2017-07-21 | （アザ−）イソキノリノン誘導体 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US9376433B2 (enExample) |
| EP (1) | EP2882714B1 (enExample) |
| JP (2) | JP6247294B2 (enExample) |
| KR (1) | KR102083154B1 (enExample) |
| CN (1) | CN104507912B (enExample) |
| AR (1) | AR092366A1 (enExample) |
| AU (1) | AU2013301870B2 (enExample) |
| BR (1) | BR112015002601A2 (enExample) |
| CA (1) | CA2881330C (enExample) |
| DK (1) | DK2882714T3 (enExample) |
| ES (1) | ES2773272T3 (enExample) |
| HR (1) | HRP20200180T1 (enExample) |
| HU (1) | HUE047608T2 (enExample) |
| IL (1) | IL237072B (enExample) |
| LT (1) | LT2882714T (enExample) |
| MX (1) | MX362939B (enExample) |
| PL (1) | PL2882714T3 (enExample) |
| PT (1) | PT2882714T (enExample) |
| RS (1) | RS59921B1 (enExample) |
| RU (1) | RU2654216C2 (enExample) |
| SG (1) | SG11201500732TA (enExample) |
| SI (1) | SI2882714T1 (enExample) |
| WO (1) | WO2014023390A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2942847B2 (ja) | 1990-06-22 | 1999-08-30 | ダイセル化学工業株式会社 | 液晶性ポリマーフィルムの製造装置とそれを用いた液晶性ポリマーフィルムの製造方法 |
| EP2822656B1 (en) | 2012-03-07 | 2016-10-19 | Institute of Cancer Research: Royal Cancer Hospital (The) | 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use |
| WO2014087165A1 (en) * | 2012-12-06 | 2014-06-12 | University Of Bath | Tankyrase inhibitors |
| EP3044221B1 (en) | 2013-09-11 | 2018-02-21 | Institute of Cancer Research: Royal Cancer Hospital (The) | 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use |
| UY36060A (es) | 2014-04-02 | 2015-10-30 | Bayer Pharma AG | Compuestos de azol sustituidos con amida |
| WO2015154630A1 (zh) * | 2014-04-10 | 2015-10-15 | 南京明德新药研发股份有限公司 | 作为PARP抑制剂的4H-吡唑并[1,5-α]苯并咪唑化合物的类似物 |
| CN105153156B (zh) * | 2015-09-22 | 2017-07-28 | 徐峰 | 一种4‑苯基‑2,7‑萘啶‑1（2h）‑酮的制备方法 |
| WO2017055316A1 (en) | 2015-10-01 | 2017-04-06 | Bayer Pharma Aktiengesellschaft | Amido-substituted azole compounds |
| WO2017055313A1 (en) | 2015-10-01 | 2017-04-06 | Bayer Pharma Aktiengesellschaft | Amido-substituted azole compounds |
| US10722484B2 (en) | 2016-03-09 | 2020-07-28 | K-Gen, Inc. | Methods of cancer treatment |
| WO2017160898A1 (en) * | 2016-03-15 | 2017-09-21 | Purdue Research Foundation | Aza-a-ring indenoisoquinoline topoisomerase i poisons |
| WO2018078005A1 (en) | 2016-10-29 | 2018-05-03 | Bayer Pharma Aktiengesellschaft | Amido-substituted azaspiro derivatives as tankyrase inhibitors |
| WO2018078009A1 (en) | 2016-10-29 | 2018-05-03 | Bayer Pharma Aktiengesellschaft | Amido-substituted cyclohexane derivatives |
| WO2018087126A1 (en) | 2016-11-09 | 2018-05-17 | Bayer Pharma Aktiengesellschaft | Amido-substituted cyclohexane derivatives as inhibitors of tankyrase |
| JP7182548B2 (ja) | 2016-12-22 | 2022-12-02 | パードゥ リサーチ ファウンデーション | アザインデノイソキノリン化合物およびその使用 |
| US10899733B2 (en) | 2017-08-23 | 2021-01-26 | Oregon Health & Science University | Inhibitors of PARPs that catalyze mono-ADP-ribosylation |
| RU2709928C1 (ru) * | 2019-02-21 | 2019-12-24 | Федеральное государственное бюджетное научное учреждение "Институт природно-технических систем" (ИПТС) | Датчик удельной электропроводности |
| WO2024029583A1 (ja) * | 2022-08-05 | 2024-02-08 | 国立研究開発法人理化学研究所 | 新規ピラゾール誘導体及びその用途 |
| GB2634228A (en) * | 2023-10-02 | 2025-04-09 | Duke Street Bio Ltd | PARP1 inhibitor compounds |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| PL194689B1 (pl) | 1996-02-13 | 2007-06-29 | Astrazeneca Uk Ltd | Pochodne chinazoliny, ich kompozycje farmaceutyczne oraz ich zastosowania |
| EP0885198B1 (en) | 1996-03-05 | 2001-12-19 | AstraZeneca AB | 4-anilinoquinazoline derivatives |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| US6197785B1 (en) * | 1997-09-03 | 2001-03-06 | Guilford Pharmaceuticals Inc. | Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity |
| WO1999011622A1 (en) * | 1997-09-03 | 1999-03-11 | Guilford Pharmaceuticals Inc. | Amino-substituted compounds, methods, and compositions for inhibiting parp activity |
| US6340759B1 (en) | 1997-10-02 | 2002-01-22 | Eisai Co., Ltd. | Fused pyridine derivatives |
| JP3989102B2 (ja) * | 1997-10-02 | 2007-10-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 縮合ピリジン誘導体 |
| ID27843A (id) * | 1998-08-11 | 2001-04-26 | Pfizer Prod Inc | Substitusi 1, 8-naftiridin-4(ih)-on sebagai penghambat fosfodiesterase 4 |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| EP1289952A1 (en) | 2000-05-31 | 2003-03-12 | AstraZeneca AB | Indole derivatives with vascular damaging activity |
| WO2002008213A1 (en) | 2000-07-07 | 2002-01-31 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as angiogenesis inhibitors |
| CN1255391C (zh) | 2000-07-07 | 2006-05-10 | 安吉奥金尼药品有限公司 | 作为血管破坏剂的colchinol衍生物 |
| MY140680A (en) * | 2002-05-20 | 2010-01-15 | Bristol Myers Squibb Co | Hepatitis c virus inhibitors |
| WO2005075432A1 (ja) * | 2004-02-06 | 2005-08-18 | Chugai Seiyaku Kabushiki Kaisha | １−（２ｈ）−イソキノロン誘導体およびその抗ガン剤としての使用 |
| US7772180B2 (en) * | 2006-11-09 | 2010-08-10 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| KR101444489B1 (ko) | 2007-02-01 | 2014-09-24 | 리스버로직스 코퍼레이션 | 심혈관 질환을 예방 및 치료하기 위한 화합물 |
| CA2678248C (en) | 2007-03-08 | 2016-06-28 | Janssen Pharmaceutica Nv | Quinolinone derivatives as parp and tank inhibitors |
| TWI499418B (zh) | 2009-05-21 | 2015-09-11 | Nerviano Medical Sciences Srl | 異喹啉－１（２ｈ）－酮衍生物 |
| FR2956816B1 (fr) | 2010-03-01 | 2012-05-18 | Univ Joseph Fourier | Utilisation de quinolones pour la preparation de medicaments, nouvelles quinolones et leur procede de synthese |
| US8957203B2 (en) * | 2011-05-05 | 2015-02-17 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| EP2822656B1 (en) * | 2012-03-07 | 2016-10-19 | Institute of Cancer Research: Royal Cancer Hospital (The) | 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use |
| US20130311482A1 (en) | 2012-05-17 | 2013-11-21 | Tagged, Inc. | Multi-user timeline for facilitating social discovery in social networking environments |
-
2013
- 2013-07-12 HR HRP20200180TT patent/HRP20200180T1/hr unknown
- 2013-07-12 SI SI201331671T patent/SI2882714T1/sl unknown
- 2013-07-12 CA CA2881330A patent/CA2881330C/en active Active
- 2013-07-12 DK DK13737146.4T patent/DK2882714T3/da active
- 2013-07-12 WO PCT/EP2013/002085 patent/WO2014023390A2/en not_active Ceased
- 2013-07-12 PT PT137371464T patent/PT2882714T/pt unknown
- 2013-07-12 ES ES13737146T patent/ES2773272T3/es active Active
- 2013-07-12 RU RU2015107702A patent/RU2654216C2/ru active
- 2013-07-12 MX MX2015001545A patent/MX362939B/es active IP Right Grant
- 2013-07-12 LT LTEP13737146.4T patent/LT2882714T/lt unknown
- 2013-07-12 HU HUE13737146A patent/HUE047608T2/hu unknown
- 2013-07-12 EP EP13737146.4A patent/EP2882714B1/en active Active
- 2013-07-12 CN CN201380041848.2A patent/CN104507912B/zh not_active Expired - Fee Related
- 2013-07-12 RS RS20200154A patent/RS59921B1/sr unknown
- 2013-07-12 US US14/420,578 patent/US9376433B2/en not_active Expired - Fee Related
- 2013-07-12 JP JP2015525763A patent/JP6247294B2/ja not_active Expired - Fee Related
- 2013-07-12 AU AU2013301870A patent/AU2013301870B2/en not_active Ceased
- 2013-07-12 PL PL13737146T patent/PL2882714T3/pl unknown
- 2013-07-12 BR BR112015002601A patent/BR112015002601A2/pt not_active Application Discontinuation
- 2013-07-12 KR KR1020157005977A patent/KR102083154B1/ko not_active Expired - Fee Related
- 2013-07-12 SG SG11201500732TA patent/SG11201500732TA/en unknown
- 2013-08-07 AR ARP130102805A patent/AR092366A1/es unknown
-
2015
- 2015-02-03 IL IL237072A patent/IL237072B/en active IP Right Grant
-
2017
- 2017-07-21 JP JP2017142160A patent/JP6333450B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015524450A5 (enExample) | ||
| JP2015515961A5 (enExample) | ||
| RU2015107702A (ru) | Производные (аза-)изохинолинона | |
| HRP20161033T1 (hr) | Derivati pirolotriazinona | |
| JP2015529229A5 (enExample) | ||
| JP2015535831A5 (enExample) | ||
| JP2015509512A5 (enExample) | ||
| JP2020097596A5 (enExample) | ||
| JP2015511609A5 (enExample) | ||
| RU2009127095A (ru) | Новые оксадиазольные соединения | |
| HRP20171053T1 (hr) | Derivati oksokinazolinil-butanamida | |
| JP2013510124A5 (enExample) | ||
| RU2015115278A (ru) | Производные гидропирролопиррола для применения в качестве ингибиторов синтазы жирных кислот | |
| JP2009514870A5 (enExample) | ||
| JP2014518884A5 (enExample) | ||
| JP2010532768A5 (enExample) | ||
| RU2009121577A (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-b]ПИРИДАЗИНА И ПИРАЗОЛО[1,5-a]ПИРИМИДИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРА ПРОТЕИНКИНАЗ | |
| RU2015115576A (ru) | Производные хиназолинона в качестве ингибиторов parp | |
| RU2016137832A (ru) | Соединения для лечения опосредованных комплементом нарушений | |
| RU2015117251A (ru) | Новые соединения | |
| JP2010500293A5 (enExample) | ||
| JP2013508382A5 (enExample) | ||
| JP2005529089A5 (enExample) | ||
| ME02838B (me) | 3,4-dihidroizokinolin-2(1h)-ilni spojevi | |
| RU2016147727A (ru) | Гетероциклилбутанамидные производные |